Health In Tech Inc (HIT)

Offering of 300m news just posted, dang it

June 20th ipo lock up period ends,my guess they would like share price higher when they are able to sell (I would want $10 lol) https://investorshub.advfn.com/stock-market/NASDAQ/health-in-tech-HIT/stock-news/97357733/health-in-tech-announces-voluntary-extension-of-lo

Good to see you ollik! You have been posting many great plays ,thanks for sharing! 852 HIT watchers on s t , just you and I on here (like many plays ,we are the first good skill bro!

Add … nice tipp … Follow the money … 

HIT 1.07 ,zero borrow today,dropped from 150k, $34m sales ,86% insiders,private placement in March, 9m float / 7% short,charting up off oversold,parabolic stop and res. Flipped to buy, watch for news and after mkt run or tomorrow,something is coming if they aren’t loaning out shares to short (they want them for the run up
Good skill everyone!!!

Charting up,started zero borrow today ,Monday was 150k shares,yesterday dropped to 10k ,today is zero borrow,something good could be coming after mkt today or tomorrow ,they are hoarding shares

https://investorshub.advfn.com/stock-market/NASDAQ/health-in-tech-HIT/trades

Started loading 1.06 ,zero borrow today

Health In Tech Announces Closing of $7.0 Million Private PlacementMarch 27, 2026 4:00 PM
PR Newswire (US)

STUART, Fla., March 27, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced the closing of its previously announced private investment in public equity financing (the "PIPE"), resulting in gross proceeds of approximately $7.0 million before deducting placement agent fees and offering expenses.







The PIPE included participation from institutional investors and accredited investors. The Company issued an aggregate of 5,600,000 shares of common stock at a price of $1.25 per share.Craig-Hallum Capital Group LLC acted as the sole placement agent for the PIPE. Loeb & Loeb LLP acted as counsel to the Company. Faegre Drinker Biddle & Reath LLP acted as counsel to the placement agent.Strengthening Financial Flexibility to Support Strategic Growth"This financing strengthens our ability to accelerate the next phase of our platform development," said Tim Johnson, Chief Executive Officer of Health In Tech. "The additional capital will support key technology initiatives and help us bring new product capabilities to market that our clients have been actively requesting. As we continue expanding the functionality of our platform, we believe it will deepen customer engagement and support sustained, scalable revenue growth."Use of ProceedsThe Company intends to use the net proceeds from the private placement for:Expansion of sales distributionAdvance technology developmentSupport new product developmentGeneral corporate purposes and working capital"In addition, the transaction introduces new long-term institutional investors to our shareholder base," said Julia Qian, Chief Financial Officer of Health In Tech. "We believe this will enhance market visibility and support our broader capital markets strategy while providing flexibility to continue investing in our technology and growth initiatives."The securities described above are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and/or Regulation D promulgated thereunder, and have not been registered under the Securities Act or applicable state securities laws. Accordingly, the securities issued in the PIPE may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to a registration rights agreement with the PIPE investors, the Company has agreed to file a resale registration statement with the Securities and Exchange Commission registering the resale of the shares of Class A common stock described above.Use of Forward-Looking StatementsCertain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity. Health In Tech undertakes no obligation to update any forward-looking statements, except as required by law.About Health In Tech Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators ("TPAs"). Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration.Investor Contact:
Health In Tech Investor Relations
ir@healthintech.comThe Equity Group
Kalle Ahl, CFA
T: (303) 953-9878
kahl@theequitygroup.comDevin Sullivan, Managing Director
dsullivan@theequitygroup.com



View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-closing-of-7-0-million-private-placement-302727315.htmlSOURCE Health In Tech Inc.

Original: Health In Tech Announces Closing of $7.0 Million Private Placement

Health In Tech Announces $7.0 Million Private PlacementMarch 25, 2026 5:38 PM
PR Newswire (US)

STUART, Fla., March 25, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced that it has entered into a securities purchase agreement for a private investment in public equity financing (the "PIPE") that is expected to result in gross proceeds of approximately $7.0 million before deducting placement agent fees and offering expenses. The PIPE is expected to close on or about March 27, 2026, subject to the satisfaction of customary closing conditions.Pursuant to the terms of the securities purchase agreement, at the closing of the PIPE, Health In Tech will issue an aggregate of 5,600,000 shares of Class A common stock at a price of $1.25 per share.Craig-Hallum Capital Group LLC acted as the sole placement agent for the PIPE.The Company intends to use the net proceeds from the PIPE to expand sales distribution, advance technology development, support new product development, and for general corporate purposes and working capital.The securities described above are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and/or Regulation D promulgated thereunder, and have not been registered under the Securities Act or applicable state securities laws. Accordingly, the securities issued in the PIPE may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to a registration rights agreement with the PIPE investors, the Company has agreed to file a resale registration statement with the Securities and Exchange Commission registering the resale of the shares of Class A common stock described above.This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.Use of Forward-Looking StatementsCertain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity. Health In Tech undertakes no obligation to update any forward-looking statements, except as required by law.About Health In Tech Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators ("TPAs"). Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration.Investor Contact:Health In Tech Investor Relations
ir@healthintech.comThe Equity Group   
Kalle Ahl, CFA                   
T: (303) 953-9878  
kahl@theequitygroup.comDevin Sullivan, Managing Director
dsullivan@theequitygroup.com



View original content:https://www.prnewswire.com/news-releases/health-in-tech-announces-7-0-million-private-placement-302725416.htmlSOURCE Health In Tech Inc.

Original: Health In Tech Announces $7.0 Million Private Placement

Health In Tech Announces Fourth Quarter and Full Year 2025 Financial ResultsMarch 25, 2026 4:05 PM
PR Newswire (US)

Full year 2025 Revenues of $33.3 million, up 71% YoYFull year 2025 Adjusted EBITDA of $4.1 million, up 81% YoYSTUART, Fla., March 25, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or "Company"), an AI-enabled InsurTech platform company, today announced its financial results for the fourth quarter and full year ended December 31, 2025.







Financial Highlights for the Full Year 2025 and Fourth Quarter of 2025: Revenues. Full year 2025 revenues were $33.3 million, up 71% year over year ("YoY"). Q4 revenues were $7.5 million, up 53% YoY.Adjusted EBITDA. Full year 2025 Adjusted EBITDA was $4.1 million, up 81% YoY, Q4 Adjusted EBITDA of $0.3 million compared to prior year Q4 Adjusted EBITDA of $0.5 million.Net Income. Full year 2025 net income was $1.3 million, up 91% YoY, Q4 net loss of $0.3 million compared to prior year Q4 net loss of $0.1 million.Billed Enrolled Employees. The number of billed enrolled employees (EEs) was 22,515 as of December 31, 2025, up 23% YoY.Distribution. The number of Brokers, Third-party Administrator ("TPAs") and Agencies expanded to 858 partners as of December 31, 2025, up 34% YoY.Cash. Cash balance was $7.7 million as of December 31, 2025.Revenue OutlookHealth In Tech expects full-year 2026 revenue to be in the range of $45 million to $50 million, representing year-over-year growth of approximately 35% to 50%. This outlook is based on management's current expectations and assumptions, including continued strong demand for the Company's AI-enabled underwriting marketplace across the self-funded health insurance segment and successful deployment of new features. Actual results may differ materially due to risks and uncertainties described in Health In Tech's filings with the SEC.The Company expects continued growth driven by expanding engagement across its distribution network and the full deployment of new features launched in January 2026. Unlike the traditional insurance industry, where new product and service implementations typically require one to two years, Health In Tech's AI-driven platform enables new capabilities to be developed and deployed within approximately one to two quarters. This accelerated development cycle provides a meaningful competitive advantage, allowing the Company to respond quickly to broker and client demand, continuously enhance its marketplace offerings, and scale its technology platform more efficiently than traditional market participants.CEO Commentary Tim Johnson, Chief Executive Officer of Health In Tech, commented, "2025 was a defining year of disciplined execution and measurable platform scale for Health In Tech. We strengthened our AI-enabled underwriting marketplace, expanded carrier, broker, and TPA integrations, and further automated core insurance workflows to drive efficiency and margin scalability. We extended underwriting capabilities into larger employer segments and continued enhancing our technology architecture to support enterprise-level throughput across the approximately $300 billion U.S. claims administration market. Most importantly, we translated operational progress into financial performance, delivering 71% year-over-year revenue growth."Mr. Johnson continued, "As we enter 2026, our focus is on advancing a fully integrated marketplace model that expands beyond underwriting to include additional services such as claims administration and administrative cost-containment solutions. Building on years of assembling specialized healthcare vendors and service providers essential to self-funded plans, we enhanced our platform in January 2026 to offer more than 100 pre-configured, customized stop-loss programs tailored at the broker-agency level. This structured program architecture enables agencies to align standardized offerings with target employer segments, empowering brokers to deliver execution-ready solutions with greater speed, consistency, and operational efficiency. The result is shorter sales cycles, improved conversion visibility, and scalable distribution leverage, while maintaining the flexibility to customize for employer-specific needs."In the first half of 2026, we expect to complete market testing of our Three-Year Rate stabilization program, designed to provide cost stability and predictability for eligible employer groups. We also plan to initiate beta testing of a new data-driven solution that integrates physiological data and claims data to generate actionable value insights. Together, these initiatives reflect our strategy of layering incremental, high-value services onto an already commercialized and scalable platform to drive durable growth and increasing operating leverage."Key Developments in Q1 2026 Engaged Amazon Web Services (AWS) Advanced Tier Services Partner Ciklum to accelerate development of Health In Tech's AI-Driven InsurTech platform.Appointed former SAP and IBM executive Sri Rajagopalan as Chief Technology Officer to advance AI-driven Enterprise-Grade platform growth.Appointed five-time founder Zain Hasan as Chief Growth Officer to accelerate revenue growth and scale distribution.Introduced 100+ pre-configured stop-loss self-funded healthcare plans for employers, streamlining the renewal process and reducing cycle times.Hosted the inaugural independent hitDavos InsurTech Summit during World Economic Forum Week 2026, driving brand visibility and global leadership engagement across the government, technology, healthcare, and finance sectors.Conference Call DetailsHealth In Tech will host a conference call to discuss the financial results for the fourth quarter and full year of 2025 on March 25, 2026, at 5:00 p.m. (ET). To participate in our live conference call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants).A live audio webcast will be available via the Investor Relations page of Health In Tech's website at https://healthintech.com/. A replay of the webcast will be available for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.Non-GAAP Financial InformationThis release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). Management uses Adjusted EBITDA to provide investors with additional insight into operational performance and to facilitate comparison with other companies in the industry. Adjusted EBITDA should not be considered an alternative to net income, operating income, or other GAAP measures. A reconciliation of historical non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.Use of Forward-Looking StatementsCertain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.About Health In Tech Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators ("TPAs"). Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration. Learn more at healthintech.com. Health In Tech, Inc.Consolidated Statements of Operations


Three Months Ended
December 31,
Fiscal Year Ended December 31,


2025
2024
2025
2024
Revenues










Revenues from underwriting modeling
     (ICE)
$1,032,381
$1,697,080
$6,864,545
$6,649,271


Revenues from fees
6,476,204
3,207,484
26,462,966
12,841,635


    SMR
6,476,204
2,470,284
26,462,966
9,849,300


    HI Card
-
737,200
-
2,992,335


Total revenues
7,508,585
4,904,564
33,327,511
19,490,906


Cost of revenues
3,379,942
1,107,173
12,389,783
4,051,439


Gross profit
4,128,643
3,797,391
20,937,728
15,439,467


Operating expenses










Sales and marketing expenses
906,206
632,060
4,185,766
3,158,257


General and administrative expenses
3,180,137
2,848,014
13,654,262
8,477,407


Research and development expenses
213,113
633,653
1,569,262
2,813,899


Total operating expenses
4,299,456
4,113,727
19,409,290
14,449,563


Other income (expense):










Interest income
104,659
28,774
409,922
122,885


Interest expenses
-
-
-
(495,000)


Other income
-
114,055
118,399
271,211


Other expense
(377,587)
62,759
(382,587)
-


Total other income (expense), net
(272,928)
205,588
145,734
(100,904)


Income (loss) before income tax
     expense
$(443,741)
$(110,748)
$1,674,172
$889,000


Provision for income taxes
141,184
(33,404)
(395,330)
(218,523)


Net income (loss)
$(302,557)
$(144,152)
$1,278,842
$670,477


Net income per share










Basic
$(0.01)
$(0.00)
$0.02
$0.01


Diluted
$(0.01)
$(0.00)
$0.02
$0.01


Weighted average common stocks
     outstanding










Basic
56,908,999
52,047,723
55,843,821
51,839,329


Diluted
58,635,562
54,662,931
57,742,798
53,662,677


  Health In Tech, Inc.Consolidated Balance Sheets


December 31, 2025
December 31, 2024
Assets           





Current assets





Cash and cash equivalents
$7,669,754
$7,849,248

  Accounts receivable, net
756,288
1,647,103

  Loans receivable, net
815,995
-

  Other receivables, net
3,467,814
500,252

  Deferred offering costs
170,977
-

  Prepaid expenses and other current assets
3,280,148
787,161

Total current assets
16,160,976
10,783,764

Non-current assets





  Software
6,530,894
3,962,461

  Loans receivable, net
-
815,995

  Operating lease - right of use assets
139,940
206,269

  Long-term prepaid expenses
258,151
-

Total non-current assets
6,928,985
4,984,725

Total assets
$23,089,961
$15,768,489

Liabilities and stockholders' equity





Current liabilities





Accounts payable and accrued expenses
$4,188,811
$1,858,840

Income taxes payable
-
205,253

Operating lease liabilities - current
76,195
66,881

Other current liability
891,598
-

Total current liabilities
5,156,604
2,130,974

Non-current liabilities





Deferred tax liabilities
757,675
328,676

Operating lease liabilities - non-current
63,617
139,811

Total non-current liabilities
821,292
468,487

Total liabilities
5,977,896
2,599,461

Stockholders' equity





Common stock, $0.001 par value; Class A Common
   stock 150,000,000 shares authorized 46,006,000 and
   42,914,870 shares issued and outstanding as of
   December 31, 2025 and December 31, 2024,
   respectively
46,006
42,915

Common stock, $0.001 par value; Class B Common
   stock 50,000,000 shares authorized, 11,700,000
   shares issued and outstanding as of December 31,
   2025 and December 31, 2024, respectively
11,700
11,700

Additional paid-in capital
11,834,121
9,173,017

Retained earnings
5,220,238
3,941,396

Total stockholders' equity
17,112,065
13,169,028

Total liabilities and stockholders' equity
$23,089,961
$15,768,489

  Health In Tech, Inc.Consolidated Statements of Cash Flows


Fiscal Year Ended December 31,

2025
2024CASH FLOWS FROM OPERATING ACTIVITIES:   




Net income
$1,278,842
$670,477
Adjustments to reconcile net income to net cash provided by
(used in) operating activities:




  Bad debt expense (recovery)
(16,234)
1,878
  Amortization expense
900,577
541,141
  Provision for refund liability
3,891,598
-
  Provision for credit losses on other receivables
377,587
-
Deferred tax expenses (benefits)
428,999
(93,304)
Amortization of debt discount
-
495,000
Interest income
(64,000)
(63,996)
Stock-based compensation expense
1,570,419
468,489
Changes in operating assets and liabilities:




Accounts receivable
907,049
586,685
Other receivables
(3,345,149)
1,180,848
Prepaid expenses and other assets
(1,948,184)
(514,242)
Operating lease right of use assets and liabilities, net
(551)
1,889
Accounts payable and accrued expenses
2,358,113
(851,963)
Income taxes payable
(205,253)
(246,693)
Other current liabilities
(3,000,000)
-
Net cash provided by operating activities
3,133,813
2,176,209
CASH FLOWS FROM INVESTING ACTIVITIES:




Development of software
(3,189,921)
(900,755)
Interest received from loans receivable
64,000
64,000
Net cash used in investing activities
(3,125,921)
(836,755)
CASH FLOWS FROM FINANCING ACTIVITIES:




Proceeds from issuance of common stock in connection with
initial public offering, net of underwriting discounts and
commissions
-
8,214,000
Proceeds from stock option exercises
23,430
-
Payments of deferred offering costs
(210,816)
(1,975,556)
Repayments of notes payable
-
(2,145,000)
Net cash provided by (used in) financing activities
(187,386)
4,093,444
Increase (decrease) in cash and cash equivalents
(179,494)
5,432,898
Cash and cash equivalents, beginning of year
7,849,248
2,416,350
Cash and cash equivalents, end of year
7,669,754
7,849,248
Supplemental disclosures of cash flow information:




Cash paid for interest
$-
$-
Cash paid for income taxes
$830,726
$558,521
Summary of noncash investing and financing activities:




Accrued deferred offering costs included in accounts
     payable and accrued expenses
$-
$39,839
Accrued development of software included in accounts
     payable and accrued expenses
$38,363
$50,000
Reclassification of deferred offering costs to additional paid-
     in capital upon initial public offering
$-
$2,277,164
Stock-based compensation capitalized for software
     development
$290,726
$-
  Health In Tech, Inc.Reconciliation of GAAP (Net Income) to Non-GAAP Financial Measure (Adjusted EBITDA)


Three Months Ended December 31,
Fiscal Year EndedDecember 31,

2025
2024
2025
2024Net income
(302,557)
(144,152)
1,278,842
670,477Interest (income) expenses
(104,659)
(28,774)
(409,922)
372,115Amortization expense
410,630
135,983
900,577
541,141Income tax expense
(141,184)
33,404
395,330
218,523Stock-based compensation expense
76,733
468,489
1,570,419
468,489Provision for credit losses on other
     receivables
377,587
-
377,587
-Total net adjustments
619,107
609,102
2,833,991
1,600,268








Adjusted EBITDA
316,550
464,950
4,112,833
2,270,745   Investor Contact:
Health In Tech Investor Relations
ir@healthintech.comThe Equity Group
Kalle Ahl, CFA          
T: (303) 953-9878     
kahl@theequitygroup.comDevin Sullivan, Managing Director
dsullivan@theequitygroup.com



View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-fourth-quarter-and-full-year-2025-financial-results-302725203.htmlSOURCE Health In Tech Inc.

Original: Health In Tech Announces Fourth Quarter and Full Year 2025 Financial Results

HIT.........................................p/m

Health In Tech and Amazon Web Service Advanced Tier Service Partner Ciklum Announce Strategic Collaboration to Accelerate Development of AI-Driven InsurTech PlatformMarch 17, 2026 4:01 PM
PR Newswire (US)

STUART, Fla., March 17, 2026 /PRNewswire/ -- Health In Tech, Inc. (the "Company" or "Health In Tech") (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced a strategic collaboration with Ciklum, a global AI-powered experience engineering and software development firm, to enhance the Company's AI-driven InsurTech platform. The HIT's platform operates as an  integrated self-funded stop-loss health insurance marketplace serving more than 800 insurance brokers, third party administrators (TPAs), managing general underwriters (MGUs) and carriers in 40 states. 







Ciklum's collaboration will optimize the platform's administrative, sales, and analytics capabilities. This initiative will expand both front- and back-end functionality to create an integrated technology environment—from AI-driven bindable quotes to AI-enabled financial reporting and analytics—while streamlining data infrastructure and reporting processes which all hosted on Amazon Web Services (AWS).Ciklum, an AWS Advanced Tier Services Partner, provides enterprise-grade software engineering services to Fortune 500 companies and high-growth technology organizations worldwide. Through this collaboration, Health In Tech expects to leverage Ciklum's deep technical expertise in AWS architecture, data engineering, and AI-driven software development to accelerate platform innovation and scalability.The Company anticipates successful implementation of these enhancements will deliver expected benefits including:Enhanced platform capabilities and administrative functions, enabling service partners to more efficiently support existing clients while potentially expanding into larger employer marketsImproved integration of front- and back-end workflows, consolidating quoting, underwriting, administration, and analytics into a unified platform with the goal of increasing usability and adoptionAdvanced data, operational reporting capabilities, which aims to deliver deeper insights and improved decision-making for brokers, TPAs, MGUs, carriers, and employer clientsTim Johnson, Chief Executive Officer of Health In Tech, commented, "Health in Tech was founded on the belief that self-funded stop-loss insurance should be simple, streamlined, and widely available. Consistent with our commitment to continuous improvement, we are thrilled to partner with Ciklum, a premier technical and software development company that possesses a full range of capabilities and expertise on our cloud platform, AWS. In addition to achieving AWS Advanced Tier Service partner status, Ciklum has accumulated deep domain experience across healthcare and health insurance and stands out through its AI-powered approach to experience engineering. Together, we are building integrated solutions designed to eliminate fragmented workflows and multiple system dependencies, improving the user experience for brokers, administrators, MGU and carrier partners. This collaboration reflects the strategic technology investments we are making today with the goal of supporting greater platform adoption, stronger customer retention, and long-term revenue growth.""Health in Tech is redefining how self-funded stop-loss insurance is delivered, bringing simplicity, transparency, and scalability to a complex ecosystem," said Raj Radhakrishnan, CEO of Ciklum. "At Ciklum, we are excited to partner with innovators that use technology to reshape industries. By combining Health in Tech's vision with our deep healthcare expertise, cloud-native engineering on AWS, and our Prodigy AI framework, we are building solutions that unify fragmented systems and deliver breakthrough improvements in operational efficiency.This partnership will leverage our years of experience and track record in delivering scalable AI-native platforms for leading enterprises, and we look forward to driving innovation and long-term impact for Health In Tech's customers and partners."About Ciklum Ciklum (www.ciklum.com) is a global experience engineering firm that stands at the forefront of innovation, blending next-generation product engineering, exceptional customer experiences, and cutting-edge AI. It revolutionizes the way people live by developing groundbreaking technologies that reimagine, reshape, and redefine the future. For more than two decades, Ciklum has been a trusted partner to both global enterprises and digital disruptors, spearheading the creation of digital solutions that not only tackle complex corporate challenges but also propel businesses toward accelerated growth and success. Ciklum has a vast global team of over 4,000 highly skilled engineers, experience design specialists, product owners and consultants.About Health In Tech Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators ("TPAs").  Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration. Learn more at healthintech.com.Forward Looking StatementsThis press release may contain forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.  Health In Tech undertakes no obligation to update any forward-looking statements, except as required by lawInvestor Contact:
Health In Tech Investor Relations
ir@healthintech.com
The Equity GroupKalle Ahl, CFA      
T: (303) 953-9878
kahl@theequitygroup.comDevin Sullivan, Managing Director
dsullivan@theequitygroup.com










View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-and-amazon-web-service-advanced-tier-service-partner-ciklum-announce-strategic-collaboration-to-accelerate-development-of-ai-driven-insurtech-platform-302716452.htmlSOURCE Health In Tech Inc.

Original: Health In Tech and Amazon Web Service Advanced Tier Service Partner Ciklum Announce Strategic Collaboration to Accelerate Development of AI-Driven InsurTech Platform

Health In Tech to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026March 9, 2026 7:00 AM
PR Newswire (US)

STUART, Fla., March 9, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2025, following the close of market on Wednesday, March 25, 2026. Health In Tech will host a conference call and live webcast to discuss the Company's financial results, recent developments and business outlook.Event: Health In Tech's Fourth Quarter and Full Year 2025 Earnings Conference CallWhen: Wednesday, March 25, 2026, at 5:00 p.m. ETLive Call:PARTICIPANT DIAL IN (TOLL FREE): 1-888-346-8982
PARTICIPANT INTERNATIONAL DIAL IN: 1-412-902-4272Webcast Link:https://event.choruscall.com/mediaframe/webcast.html?webcastid=aaEknIjbReplay: A webcast replay will be available on Health In Tech's investor relations website at https://healthintech.investorroom.com/ shortly after the completion of the call, and will remain available for approximately 90 days.About Health In Tech Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and third party administrators. Learn more at healthintech.com.Forward-Looking StatementsCertain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.Investor ContactInvestor Relations:
ir@healthintech.com



View original content:https://www.prnewswire.com/news-releases/health-in-tech-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-march-25-2026-302707299.htmlSOURCE Health In Tech Inc.

Original: Health In Tech to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026

Health In Tech Appoints Former SAP and IBM Executive Sri Rajagopalan as Chief Technology Officer to Advance AI-driven Enterprise-Grade Platform GrowthFebruary 24, 2026 4:30 PM
PR Newswire (US)

STUART, Fla., Feb. 24, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced the appointment of Sri Rajagopalan as Chief Technology Officer (CTO), effective February 23, 2026.Mr. Rajagopalan has served as Health In Tech's Interim CTO since November 2025, during which time he has provided decisive technology leadership and advanced the company's AI-driven transformation strategy. As Interim CTO, he has strengthened architectural discipline, accelerated platform modernization, and delivered measurable execution across mission-critical technology initiatives.As Chief Technology Officer, Mr. Rajagopalan oversees end-to-end product engineering and enterprise platform operations. He is responsible for advancing Health In Tech's next-generation technology architecture and AI development roadmap and embedding artificial intelligence, automation, and data intelligence across underwriting, claims, and benefits administration workflows. His mandate includes building, scaling, and optimizing the company's cloud-native, enterprise-grade platforms to enhance performance, security, interoperability, and scalability and position Health In Tech to execute on its long-term enterprise vision and forthcoming strategic growth initiatives.Mr. Rajagopalan has more than two decades of enterprise-scale technology leadership, with global experience in software engineering, cloud transformation, data and AI platforms, and developing enterprise architecture frameworks that support large-scale operations.Prior to joining Health In Tech, Mr. Rajagopalan spent the majority of his career at SAP and IBM, two of the world's leading enterprise software companies, where he held senior leadership roles in enterprise architecture and large-scale platform engineering. His experience spans global, mission-critical systems serving complex enterprise clients across multiple industries.Since 2019, he has focused exclusively on the healthcare technology sector, serving as Senior Vice President of Software Engineering at Net Health, Senior Vice President of Platform Engineering at Zelis, and Vice President of Software Engineering & Chief Architect at Greenway Health. Across these roles, he led large engineering organizations, modernized core platforms, and scaled high-performance, transaction-intensive systems—bringing deep expertise in healthcare payments, claims technology, and data-driven platform transformation to Health In Tech. "Sri's deep enterprise architecture and large-scale platform engineering experience comes at a pivotal moment in Health In Tech's evolution," said Tim Johnson, Chief Executive Officer of Health In Tech. "He has led global engineering organizations, modernized complex legacy systems, and delivered mission-critical infrastructure at true enterprise scale. As we expand our AI-enabled underwriting and benefits administration platform, Sri will strengthen our core technology foundation—enhancing scalability, data intelligence, cybersecurity, and operational resilience. We believe his leadership positions us to support larger carrier and broker partners, execute multiple strategic initiatives in parallel, and build the enterprise-grade infrastructure required for sustained long-term growth.""Health In Tech is entering an exciting phase of technology acceleration," said Rajagopalan. "My priority is to scale a secure, cloud-native, AI-enabled platform architecture that supports high-volume transaction processing, advanced data analytics, and seamless ecosystem integrations. We will continue modernizing our engineering practices, strengthening data governance and security frameworks, and building a resilient, enterprise-class infrastructure capable of supporting rapid distribution expansion and product innovation. I look forward to leading our technology organization as we advance the next generation of Health In Tech's intelligent platform ecosystem."Use of Forward-Looking StatementsCertain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.About Health In TechHealth In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and third party administrators. Learn more at healthintech.com.Investor ContactInvestor Relations:
ir@healthintech.com 



View original content:https://www.prnewswire.com/news-releases/health-in-tech-appoints-former-sap-and-ibm-executive--sri-rajagopalan-as-chief-technology-officer-to-advance-ai-driven-enterprise-grade-platform-growth-302696243.htmlSOURCE Health In Tech Inc.

Original: Health In Tech Appoints Former SAP and IBM Executive Sri Rajagopalan as Chief Technology Officer to Advance AI-driven Enterprise-Grade Platform Growth

$HIT !!!! Multibaggas ... BEAST MODE

Now the only question is how low it goes in the pullback, and when to fire at shares here. The precipitous drop in share price earlier this year is still not explained, and the earnings report last week was very positive.

$HIT : Ohhhh yessssss oh yesssssss.............. $2.20 MAMA

BOoooooooooyaaaakkkassshhhaaaaaaaaaaaa

It was only a matter of time.......... not IF but when


GO $HIT

$HIT !

Oh yes, BEAUTIFUL EARNINGS, riding “free shares “ and keeping good amount for LONG TERM!

SOLID CALL $HIT

Early reaction to the earnings is quite good:



$1.48+$0.1300(+9.63%)
Post-market: 4:54:03 PM ET, 07/21/2025
$1.35+$0.1900(+16.38%)
At close: 4:00:00 PM ET, 07/21/2025
Bid
$1.47
Ask
$1.48

$HIT time for BLOWOUT earnings after the bell Monday peeps!!
Already at a double, and feel we be running to $2 ASAP!
Earnings report after hours this MONDAY!
I’m talking to myself since no one posts here , but what a hoot this stock and company are!

Respectfully,
Maverick
$HIT

Picked up another 11,000 shares at $1.03!
$HIT

GOING FOR GRANDSLAM Monday 7/21/25 after hours!!

BLOW OUT EARNINGS INCOMING!!

All my opinion!!

Respectfully,
Maverick
$HIT

Very nice! This is going to go gang busters when earnings comes out after market next week!
My opinion!
$HIT

It appears to be so conix. There does not appear to be any identifiable reason why HIT dropped precipitously in one day earlier this year from the $7.60+ range.

Is any of this info true?

https://www.reddit.com/r/pennystocks/comments/1lyr7rc/undervalued_and_underknown_olb_and_hit/

I think you're right about the breakout however I think the next stop is $1.52 then the clear sky breakout is after that just my opinion

FYI I have other ghost towns I’m in
$UAVS
$HIT

both are up nicely and feel free to check my posting history, on both.
I usually just talk to myself.

Since it’s just us, if you want a FUN COMMUNITY, and a GREAT STOCK along with $HIT,

Check out $DTREF
basically gold, rare earth elements etc.

Oh yea, community over there and good folks fyi! Have nice night and see you north of $1.12 tomorrow for BIG BLUE SKY BREAKOUT $HIT

All my opinion!
Respectfully
Maverick
$HIT

This thing got shorted to heck for no reason other than OUT OF CONTROL ALGOS!

$HIT is performing , doing very well , and I think you and I will just be cruising as we go up past $2 , then $3 on this silly 8 million share float!

Lmao as no one’s here.
Onward and upward!

$HIT

Haha! I think it’s just us brother!! $HIT

Alright our first $1.00 accomplished today with $HIT !

Woohoo!!
Severely undervalued here $HIT !

Those dum shorts shorted this for no reason, dumb algos .
Anyhow looking for $2 plus with earnings report , Monday, July. 21!

$HIT
Let’s hit GRANDSLAM and remember once we pass $1.12 BLUE SKIES !!

All my opinion!
Respectfully,
Maverick
$HIT

Ghost Town in here yep this thing is out performing so many others. I don't understand it even at a dollar this is still just the beginning.

For those looking at this for the first time, please know this is a great spot to start a position with HIT

I have my own $HIT load up 54% now lets see the real money on this ! 

Onward and upward .. tik tok july 21 be coming!!!
$HIT

$HIT
STAIRSTEPPING up the chart, should easily blow thru the mid and upper .80s on way to $ land!!
Massive price target came out yesterday!
SEVERELY UNDERVALUED!!

$HIT
Respectfully,
Maverick
All my opinion!

So my strategy since I like this company very much, and management as incentive plan takes stock for payment , makes me know BRIGHT FUTURE AHEAD!
30k invested for 40,000 shares! Goal is to :
1: RING THE BELL
2. Ride free shares
3. Stick to my plan!
See you in $ land this week ! All my opinion
$HIT
Respectfully,
Maverick
$HIT

.80 CAPTURED!!
Wolverines!!
$HIT let’s see our first $
$HIT SEVERELY UNDERVALUED!

All my opinion!
Let $HIT GRANDSLAM !

Respectfully,
Maverick

Likewise!! We’re ready to hit $ our first one soon!!
Very UNDERVALUED!
$HIT
GLTY hears to a $HIT GRANDSLAM!!

Respectfully,
Maverick

Great! GLTY! $HIT

Absolutely!!! $HIT
This is so undervalued and been shorted to death!!
Really stoked on this company , and the ambassador!!
Respectfully,
Maverick

Did you get those extra 10,000 shares?

Inventor 1-
Absolutely LOVE form 4s and LOVE to load even more!
Adding another 10,000 shares tomorrow for total of 40,000 shares!

SPEAKS VOLUMES with INSIDERS taking shares and form 4.

Looking for shorty to fry with earnings coming 7/21/25 and PROFITABLE on most recent quarter and a TINY, MACRO FLOAT!
Found out about this from GP22 on Orion board!
Here’s to 🚀 BACK TO $7 plus very soon!!

$HIT
Respectfully,
Maverick
$HIT
ALL MY OPINION, NOT FINANCIAL ADVISE,

four insiders accepted stock as compensation June 25 with a one year maturity, date, time to load the boats folks in my opinion

Time to see $$$ $HIT

$HIT
GRANDSLAM incoming!
Long 30,000 shares !

SEVERELY SHORTED TO DEATH, and INCREDIBLE OPPORTUNITY here in my opinion!

Ridiculous how cheap this is!
$HIT

Going for the GRANDSLAM here with 30,000 shares!
Check out website to!!!

$HIT @ .60s: Was $7 recently & massive attack....Multi-grand slam developing
I concur with this poster! GP.
SEVERE SHORT HERE!!

All my opinion!
$HIT
Respectfully,
Maverick
All my opinion!

Best it's looked since the pop and drop.

This $hit maybe finaly running 

Health In Tech's CEO Tim Johnson Discusses Company in 2025, Revenue Growth, and Healthcare on "The Street Reports Podcast" Listen Now!
https://thestreetreports.com/health-in-technologys-nasdaq-hit-ceo-tim-johnson-discusses-company-in-2025-revenue-growth-and-healthcare-on-the-street-reports-podcast-listen-now/

Promo started yesterday https://scr.zacks.com/news/news-details/2025/HIT-Leveraging-AI-Backed-Technology-to-Generate-Efficiencies--Gain-Market-Share-Amid-Broader-Industry-Digital-Transition-Initiating-Coverage-article/default.aspx